U P D A T E S

Completion of QBiotics USA veterinary anti-cancer trial in USA treating dogs with Mast Cell Tumours

October, 2018

The USA veterinary pivotal clinical study of tigilanol tiglate completes the data package for FDA and EMA submission. read more


QBiotics signs supply, marketing and distribution agreement with Virbac for canine cancer treatment

August, 2018

QBiotics Group has signed an agreement with Virbac, one of the largest dedicated animal health companies globally, to supply, market and distribute its canine anticancer pharmaceutical, tigilanol tiglate. read more